Nanoparticles vs. nanofibers: a comparison of two drug delivery systems on assessing drug release performance in vitro

In this study, the different encapsulation methods involving emulsification and coaxial electrospinning were both utilized to fabricate a series of core/sheath composite, nanoparticles (NPs) and Nanofibers (NFs) separately, for drug delivery on potential biological and therapeutic applications. Bovine serum albumin (BSA) was employed as an active pharmaceutical ingredient model for core; poly(L-lactic acid) (PLLA) and methoxy poly(ethyleneglycol)-Poly lactic acid (mPEG-PLA) were selected as the encapsulation matrix for sheath. Attributed to the optimized fabrication procedures, the obtained NPs and NFs had the small average diameters and narrow size distributions with uniform structures and smooth surface morphologies. Based on the drug release profiles, both the NPs provided a burst release process followed by a drug diffusion manner, while for the NFs, the drug diffusion was the predominant factor in drug release. In particular, the mPEG-PLA NFs were fabricated with excellent hydrophilicity and highly neutralized surface resulting in a sustained release of BSA over 10days. In addition, mPEG-PLA NFs also provided a better zero-order drug release profiles during the release time from 8 to 72h, and a one-dimensional Fickian diffusion pattern during the whole BSA release period. A cytotoxicity study suggested that the two drug delivery systems were both safe to cells. In conclusions, the synergism of PEGylation with coaxial electrospinning may be an effective way to retard the release of drugs in a more sustained manner.